Article
Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers
10 Mar 2015
Abstract excerpt
BACKGROUND: Current phenotypic testing for drug resistance in patients with tuberculosis is inadequate primarily with respect to turnaround time. Molecular tests hold the promise of an improved time to diagnosis. METHODS: A target product profile for a molecular drug-susceptibility test (DST) was developed on the basis of a collaborative effort that included opinions gathered from researchers, clinicians, policy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
